Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

País pode poupar “mais 100 milhões por ano” com genéricos

18 July 2017

Open

Europäer zahlen zu viel für Pillen

18 July 2017

Open

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Open

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Open

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Open

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

16 June 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Read more

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

Pharmaceutical industry leaders and key stakeholders from the generic, biosimilar […]

Read more

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

The European Semester Country Specific Recommendations show that healthcare systems […]

Read more

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

18 May 2017

Speaking at the B20 Health Conference in Berlin, IFPMA Director-General […]

Read more

Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe

9 May 2017

The new report on The Impact of Biosimilar Competition in […]

Read more

Subscribe to our newsletter